Asian Phytoceuticals PCL (BKK:APCO)
3.140
+0.180 (6.08%)
Mar 7, 2025, 4:12 PM ICT
Asian Phytoceuticals PCL Balance Sheet
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 62.37 | 125.63 | 82.15 | 98.59 | 100.2 | Upgrade
|
Short-Term Investments | 76.37 | 102.01 | 61.25 | 32.23 | 0.53 | Upgrade
|
Trading Asset Securities | 212.92 | 23.54 | 35.75 | 36.09 | 71.3 | Upgrade
|
Cash & Short-Term Investments | 351.66 | 251.19 | 179.15 | 166.92 | 172.04 | Upgrade
|
Cash Growth | 40.00% | 40.21% | 7.33% | -2.98% | -64.14% | Upgrade
|
Accounts Receivable | 3.38 | 0.89 | 0.98 | 0.54 | 1.75 | Upgrade
|
Other Receivables | 2.11 | 3.34 | 3.23 | 2.74 | 3.54 | Upgrade
|
Receivables | 5.49 | 4.22 | 4.21 | 3.29 | 5.29 | Upgrade
|
Inventory | 57.03 | 44.27 | 52.88 | 59.94 | 62.33 | Upgrade
|
Prepaid Expenses | 1.14 | 0.9 | 0.92 | 0.67 | 0.71 | Upgrade
|
Other Current Assets | 0.2 | 0.23 | 0.35 | 0.3 | 0.35 | Upgrade
|
Total Current Assets | 415.53 | 300.82 | 237.51 | 231.11 | 240.72 | Upgrade
|
Property, Plant & Equipment | 66.44 | 82.34 | 64.02 | 91.21 | 113.39 | Upgrade
|
Long-Term Investments | 136.11 | 303.86 | 365.01 | 346.73 | 331.93 | Upgrade
|
Other Intangible Assets | 0.61 | 0.79 | 0.24 | 0.36 | 0.5 | Upgrade
|
Long-Term Deferred Tax Assets | 11.18 | 10.75 | 7.11 | 5.05 | 4.16 | Upgrade
|
Other Long-Term Assets | 6.14 | 6.17 | 6.25 | 6.07 | 6.08 | Upgrade
|
Total Assets | 636.02 | 704.72 | 680.15 | 680.53 | 696.78 | Upgrade
|
Accounts Payable | 0.77 | 1.2 | 0.64 | 1.99 | 0.63 | Upgrade
|
Accrued Expenses | 16.08 | 16.47 | 14.46 | 14.07 | 16.87 | Upgrade
|
Current Portion of Leases | 13.2 | 13.45 | 12.2 | 18.74 | 18.42 | Upgrade
|
Current Income Taxes Payable | 5.2 | 10.77 | 12.7 | 9.64 | 9.01 | Upgrade
|
Current Unearned Revenue | 0.29 | 0.26 | 0.31 | 0.32 | 0.26 | Upgrade
|
Other Current Liabilities | 3.12 | 4.05 | 4.78 | 2.99 | 3.68 | Upgrade
|
Total Current Liabilities | 38.64 | 46.2 | 45.1 | 47.75 | 48.87 | Upgrade
|
Long-Term Leases | 10.91 | 22.22 | 1.62 | 15.49 | 31.59 | Upgrade
|
Other Long-Term Liabilities | 4.04 | 4.04 | 4.04 | 5.01 | 3.4 | Upgrade
|
Total Liabilities | 76.3 | 92.34 | 69.64 | 85.54 | 101.31 | Upgrade
|
Common Stock | 300 | 300 | 300 | 300 | 300 | Upgrade
|
Additional Paid-In Capital | 166.94 | 166.94 | 166.94 | 166.94 | 166.94 | Upgrade
|
Retained Earnings | 109.06 | 161.63 | 146.3 | 126.75 | 125.26 | Upgrade
|
Comprehensive Income & Other | -19.18 | -18.88 | -5.27 | 1.3 | 3.26 | Upgrade
|
Total Common Equity | 556.82 | 609.7 | 607.98 | 594.99 | 595.46 | Upgrade
|
Minority Interest | 2.89 | 2.69 | 2.53 | - | - | Upgrade
|
Shareholders' Equity | 559.72 | 612.39 | 610.51 | 594.99 | 595.46 | Upgrade
|
Total Liabilities & Equity | 636.02 | 704.72 | 680.15 | 680.53 | 696.78 | Upgrade
|
Total Debt | 24.11 | 35.67 | 13.82 | 34.23 | 50.01 | Upgrade
|
Net Cash (Debt) | 327.56 | 215.52 | 165.33 | 132.69 | 122.02 | Upgrade
|
Net Cash Growth | 51.98% | 30.36% | 24.60% | 8.74% | -74.57% | Upgrade
|
Net Cash Per Share | 0.54 | 0.36 | 0.28 | 0.22 | 0.20 | Upgrade
|
Filing Date Shares Outstanding | 600 | 600 | 600 | 600 | 600 | Upgrade
|
Total Common Shares Outstanding | 600 | 600 | 600 | 600 | 600 | Upgrade
|
Working Capital | 376.88 | 254.62 | 192.42 | 183.36 | 191.84 | Upgrade
|
Book Value Per Share | 0.93 | 1.02 | 1.01 | 0.99 | 0.99 | Upgrade
|
Tangible Book Value | 556.22 | 608.91 | 607.74 | 594.64 | 594.96 | Upgrade
|
Tangible Book Value Per Share | 0.93 | 1.01 | 1.01 | 0.99 | 0.99 | Upgrade
|
Land | 8.29 | 8.29 | 8.29 | 8.29 | 8.29 | Upgrade
|
Buildings | 90.24 | 93.72 | 91.07 | 91.04 | 94.77 | Upgrade
|
Machinery | 82.06 | 82.71 | 82.49 | 82.74 | 86.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.